Top New Jersey Pharma Headlines of 2015
Burgeoning strength in the economy and a robust market is driving growth within New Jersey’s bio-pharmaceutical life sciences cluster, as it now plays host to more than 3,000 companies in the pharmaceuticals and life sciences industries. This figure supports a significant rise in high quality employment and leasing activity across the region, and a remarkable increase in facility expansions and in mergers and acquisitions.
We have taken a look back over the previous year’s leading pharmaceutical and biotech headlines and summarized some of the most significant news developments:
Biotech and life sciences: Alive and well in New Jersey
Vertice Pharma Completes Acquisition of VistaPharm
The Top 10 Stocks of 2015: Biotech Companies And Netflix